These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 7578111)
1. Crystal structure of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Leishmania mexicana: implications for structure-based drug design and a new position for the inorganic phosphate binding site. Kim H; Feil IK; Verlinde CL; Petra PH; Hol WG Biochemistry; 1995 Nov; 34(46):14975-86. PubMed ID: 7578111 [TBL] [Abstract][Full Text] [Related]
2. Crystal structure of Leishmania mexicana glycosomal glyceraldehyde-3-phosphate dehydrogenase in a new crystal form confirms the putative physiological active site structure. Kim H; Hol WG J Mol Biol; 1998 Apr; 278(1):5-11. PubMed ID: 9571030 [TBL] [Abstract][Full Text] [Related]
3. Conformational changes in Leishmania mexicana glyceraldehyde-3-phosphate dehydrogenase induced by designed inhibitors. Suresh S; Bressi JC; Kennedy KJ; Verlinde CL; Gelb MH; Hol WG J Mol Biol; 2001 Jun; 309(2):423-35. PubMed ID: 11371162 [TBL] [Abstract][Full Text] [Related]
4. Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design. Aronov AM; Verlinde CL; Hol WG; Gelb MH J Med Chem; 1998 Nov; 41(24):4790-9. PubMed ID: 9822549 [TBL] [Abstract][Full Text] [Related]
5. The rational design of trypanocidal drugs: selective inhibition of the glyceraldehyde-3-phosphate dehydrogenase in Trypanosomatidae. Callens M; Hannaert V Ann Trop Med Parasitol; 1995 Dec; 89 Suppl 1():23-30. PubMed ID: 8745924 [TBL] [Abstract][Full Text] [Related]
6. Structure-based design of submicromolar, biologically active inhibitors of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase. Aronov AM; Suresh S; Buckner FS; Van Voorhis WC; Verlinde CL; Opperdoes FR; Hol WG; Gelb MH Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4273-8. PubMed ID: 10200252 [TBL] [Abstract][Full Text] [Related]
7. Evidence for the two phosphate binding sites of an analogue of the thioacyl intermediate for the Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase-catalyzed reaction, from its crystal structure. Castilho MS; Pavão F; Oliva G; Ladame S; Willson M; Périé J Biochemistry; 2003 Jun; 42(23):7143-51. PubMed ID: 12795610 [TBL] [Abstract][Full Text] [Related]
8. Structure of glycosomal glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma brucei determined from Laue data. Vellieux FM; Hajdu J; Verlinde CL; Groendijk H; Read RJ; Greenhough TJ; Campbell JW; Kalk KH; Littlechild JA; Watson HC Proc Natl Acad Sci U S A; 1993 Mar; 90(6):2355-9. PubMed ID: 8460146 [TBL] [Abstract][Full Text] [Related]
9. Selective inhibition of trypanosomal glyceraldehyde-3-phosphate dehydrogenase by protein structure-based design: toward new drugs for the treatment of sleeping sickness. Verlinde CL; Callens M; Van Calenbergh S; Van Aerschot A; Herdewijn P; Hannaert V; Michels PA; Opperdoes FR; Hol WG J Med Chem; 1994 Oct; 37(21):3605-13. PubMed ID: 7932587 [TBL] [Abstract][Full Text] [Related]
10. Cloning and characterization of the NAD-linked glycerol-3-phosphate dehydrogenases of Trypanosoma brucei brucei and Leishmania mexicana mexicana and expression of the trypanosome enzyme in Escherichia coli. Kohl L; Drmota T; Thi CD; Callens M; Van Beeumen J; Opperdoes FR; Michels PA Mol Biochem Parasitol; 1996; 76(1-2):159-73. PubMed ID: 8920004 [TBL] [Abstract][Full Text] [Related]
12. A potential target enzyme for trypanocidal drugs revealed by the crystal structure of NAD-dependent glycerol-3-phosphate dehydrogenase from Leishmania mexicana. Suresh S; Turley S; Opperdoes FR; Michels PA; Hol WG Structure; 2000 May; 8(5):541-52. PubMed ID: 10801498 [TBL] [Abstract][Full Text] [Related]
13. Design of Inhibitors for Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Enzyme of Alves KMA; Cardoso FJB; Honorio KM; de Molfetta FA Med Chem; 2020; 16(6):784-795. PubMed ID: 31309897 [TBL] [Abstract][Full Text] [Related]
14. Structural analysis of human liver glyceraldehyde-3-phosphate dehydrogenase. Ismail SA; Park HW Acta Crystallogr D Biol Crystallogr; 2005 Nov; 61(Pt 11):1508-13. PubMed ID: 16239728 [TBL] [Abstract][Full Text] [Related]
15. Purification and characterization of the native and the recombinant Leishmania mexicana glycosomal glyceraldehyde-3-phosphate dehydrogenase. Hannaert V; Callens M; Opperdoes FR; Michels PA Eur J Biochem; 1994 Oct; 225(1):143-9. PubMed ID: 7925431 [TBL] [Abstract][Full Text] [Related]
16. An unexpected phosphate binding site in glyceraldehyde 3-phosphate dehydrogenase: crystal structures of apo, holo and ternary complex of Cryptosporidium parvum enzyme. Cook WJ; Senkovich O; Chattopadhyay D BMC Struct Biol; 2009 Feb; 9():9. PubMed ID: 19243605 [TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of the cytosolic and glycosomal glyceraldehyde-3-phosphate dehydrogenase in Leishmania mexicana. Hannaert V; Blaauw M; Kohl L; Allert S; Opperdoes FR; Michels PA Mol Biochem Parasitol; 1992 Oct; 55(1-2):115-26. PubMed ID: 1435864 [TBL] [Abstract][Full Text] [Related]
18. High-resolution crystal structure of Streptococcus agalactiae glyceraldehyde-3-phosphate dehydrogenase. Zhou K; Fan X; Li Y; Zhang C; Jin T Acta Crystallogr F Struct Biol Commun; 2018 Apr; 74(Pt 4):236-244. PubMed ID: 29633972 [TBL] [Abstract][Full Text] [Related]
19. Adenosine analogues as selective inhibitors of glyceraldehyde-3-phosphate dehydrogenase of Trypanosomatidae via structure-based drug design. Bressi JC; Verlinde CL; Aronov AM; Shaw ML; Shin SS; Nguyen LN; Suresh S; Buckner FS; Van Voorhis WC; Kuntz ID; Hol WG; Gelb MH J Med Chem; 2001 Jun; 44(13):2080-93. PubMed ID: 11405646 [TBL] [Abstract][Full Text] [Related]
20. Structural analysis of glyceraldehyde 3-phosphate dehydrogenase from Escherichia coli: direct evidence of substrate binding and cofactor-induced conformational changes. Yun M; Park CG; Kim JY; Park HW Biochemistry; 2000 Sep; 39(35):10702-10. PubMed ID: 10978154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]